Skull and head muscles of Heptranchias perlo were studied. Its distinctive features include the suboccipital muscles, described for the first time, the absence of the palatoquadrate symphysis, a longitudinally extended mouth, and teeth unsuited for dissecting prey in typical method of modern sharks, which is cutting motions powered by head shaking from side to side. The palatoquadrate cartilages of H. perlo and closely related Hexanchidae articulate with the neurocranium via orbital and postorbital articulations, which together allow for lateral expansion of the jaws, but restrict retraction and protraction. We interpret these features as an adaptation to a different method of prey dissection, that is, ripping in a backward pull. It employs the specific postorbital articulation together with the suboccipital muscles as forcetransmitting devices, and is powered by swimming muscles which produce a rearward thrust of the tail. During this type of dissection, the anterior part of the vertebral column should experience a tensile stress which explains the replacement of rigid vertebral bodies by a collagenous sheath around the notochord in H. perlo. The backwardripping dissection could have been common among ancient Elasmobranchii based on the similarly developed postorbital articulation, a longitudinally extended mouth, and the absence of the palatoquadrate symphysis. A biomechanical comparison with the extinct Pucapampella indicates that ancient elasmobranchs could be also specialized in the backward-ripping prey dissection, but their mechanism was different from that inferred for H. perlo. We suggest that in the early evolution of sharks this mechanism was replaced by head-shaking dissection and then later was restored in H. perlo on a new morphological basis. A new position of the postorbital articulation below the vertebral axis is fraught with the braincase elevation when backward ripping the prey, and as a counter-mean, requires formation of suboccipital portions of the axial musculature unknown in other sharks. Homology and origin of these portions is considered.
Musculo-skeletal morphology is an indispensable source for understanding functional adaptations. Analysis of morphology of the branchial apparatus of Hexanchiform sharks can provide insight into aspects of their respiration that are difficult to observe directly. In this study, I compare the structure of the musculo-skeletal system of the gill apparatus of Heptranchias perlo and Squalus acanthias in respect to their adaptation for one of two respiratory mechanisms known in sharks, namely, the active two-pump (oropharyngeal and parabranchial) ventilation and the ram-jet ventilation. In both species, the oropharyngeal pump possesses two sets of muscles, one for compression and the other for expansion. The parabranchial pump only has constrictors. Expansion of this pump occurs only due to passive elastic recoil of the extrabranchial cartilages. In Squalus acanthias the parabranchial chambers are large and equipped by powerful superficial constrictors. These muscles and the outer walls of the parabranchial chambers are much reduced in Heptranchias perlo, and thus it likely cannot use this pump. However, this reduction allows for vertical elongation of outer gill slits which, along with greater number of gill pouches, likely decreases branchial resistance and, at the same time, increases the gill surface area, and can be regarded as an adaptation for ram ventilation at lower speeds.
Background
Although extensive research has been conducted on the role of local immunity in patients with SARS-CoV-2, little is known about the production and concentrations of secretory IgA (SIgA) in different mucosal compartments. This article aims to assess the secretion of SIgA in the nasal and pharyngeal compartments and saliva of patients with COVID-19 and to investigate the possibility and efficiency of correction of their secretion using combined intranasal and oral administration of a pharmaceutical containing antigens of opportunistic microorganisms.
Methods
This study included 78 inpatients, aged between 18 and 60 years, who had confirmed COVID-19 with moderate lung involvement. The control group (
n
=45) received basic therapy, and the treatment group (
n
=33) was additionally administered the bacteria-based pharmaceutical Immunovac VP4 from day 1 to day 10 of hospitalization. SIgA levels were measured by ELISA at baseline and on days 14 and 30.
Results
No systemic or local reactions associated with Immunovac VP4 were reported. We observed a statistically significant reduction in the duration of fever and hospitalization in patients who received Immunovac VP4 compared with those from the control group (
p
=0.03 and
p
=0.05, respectively). Changes over time in SIgA levels in nasal swabs were found to be significantly different in the two treatment groups (F=7.9,
p
[78.0]<0.001). On day 14 of observation, patients in the control group showed a statistically significant reduction in SIgA levels from baseline (
p
=0.02), whereas patients in the Immunovac VP4 group had stable SIgA levels (
p
=0.07). On day 30 after the start of treatment, there was a statistically significant increase in SIgA levels in the Immunovac VP4 group compared with baseline (from 77.7 (40.5–98.7) μg/L to 113.4 (39.8–156.7) μg/L;
p
=0.05) and the levels measured on day 14 (from 60.2 (23.3–102.9) μg/L to 113.4 (39.8–156.7) μg/L;
p
=0.03). The control group showed a statistically significant decrease in levels of nasal SIgA (to 37.3) on day 30 (
p
=0.007 for comparison with baseline values and
p
=0.04 for comparison with levels measured on day 14). Changes over time in SIgA levels measured in pharyngeal swabs were also different between the two treatment groups, and this difference reached statistical significance (F=6.5,
p
[73.0]=0.003). In the control group, this parameter did not change throughout the study (
p
=0.17 for a comparison between the levels measured on day 14 and the baseline values, and
p
=0.12 for a comparison between the levels measured on day 30 and the baseline values)....
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.